We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Newly Emerged Superbug Discovered

By LabMedica International staff writers
Posted on 15 Sep 2017
Print article
Image: The VITEK 2 COMPACT instrument offers the capacity to help improve therapeutic success and patient outcomes through reliable microbial identification (ID) and antibiotic susceptibility testing (AST) (Photo courtesy of bioMérieux).
Image: The VITEK 2 COMPACT instrument offers the capacity to help improve therapeutic success and patient outcomes through reliable microbial identification (ID) and antibiotic susceptibility testing (AST) (Photo courtesy of bioMérieux).
Hypervirulent Klebsiella pneumoniae strains often cause life-threatening community-acquired infections in young and healthy hosts, but are usually sensitive to antibiotics.

A newly emerged superbug, hyper-resistant and hypervirulent K. pneumoniae, has been discovered, which may cause untreatable and fatal infections in relatively healthy individuals and will pose enormous threat to human health.

Scientists at The Hong Kong Polytechnic University (Kowloon, Hong Kong Special Administrative Region, China) and their colleagues conducted an investigation into a fatal outbreak of pneumonia in the Second Affiliated Hospital of Zhejiang University (Hangzhou, China) in February 2016. The study involved five patients who underwent surgical operation for multiple-trauma. All of them were later infected in the intensive care unit (ICU) and developed severe pneumonia, and eventually died of septicemia and multiple organ failure. The patients were aged 53 to 73 years and were admitted to the intensive care unit between late February and April 2016.

The team collected 21 carbapenem-resistant K. pneumoniae strains from five patients and characterized these strains for their antimicrobial susceptibility, multilocus sequence types, and genetic relatedness using the VITEK-2 compact system (bioMérieux, Marcy-l'Étoile, France), multilocus sequence typing, and whole genome sequencing. The causative agent of these five patients was found to be a carbapenem-resistant K. pneumoniae (CRKP) strain, a type of previously defined superbug. Furthermore, these CRKP strains are also hypervirulent and belong to ST11 type of CRKP, the most prevalent and transmissible CRKP strains in Asia. Genomic analyses showed that the emergence of these ST11 carbapenem-resistant hypervirulent K pneumoniae strains was due to the acquisition of a roughly 170 kbp pLVPK-like virulence plasmid by classic ST11 carbapenem-resistant K. pneumoniae strains. They also detected these strains in specimens collected in other regions of China.

The ST11 CR-HvKP strains do not only infect lungs and cause pneumonia, but also invade the bloodstream and other internal organs. Due to its hypervirulence and phenotypic resistance to commonly used antibiotics, ST11 CR-HvKP strains may cause untreatable and fatal infections in relatively healthy individuals with normal immunity. The study was published on August 29, 2017, in the journal The Lancet Infectious Diseases.

Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Unit-Dose Packaging solution
HLX
New
Leishmania Test
Leishmania Real Time PCR Kit
New
Laboratory Electric Thermostat
DNP-9025A

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Molecular Diagnostics

view channel
Image: The FDA clearance for the QIAstat-Dx Respiratory Panel Mini test follows the recent approval of QIAstat-Dx Respiratory Panel Plus (Photo courtesy of QIAGEN)

Respiratory Panel to Help Clinicians Make Precise Treatment Decisions in Outpatient Settings

Respiratory tract infections are the primary reason for visits to emergency departments and subsequent hospitalizations. In the U.S., it is estimated that there are up to 41 million cases of influenza... Read more

Hematology

view channel
Image: QScout CBC will give a complete blood count in 2 minutes from fingerstick or venous blood (Photo courtesy of Ad Astra Diagnostics)

Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results

Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. The complete blood count (CBC) is a common... Read more

Pathology

view channel
Image: The new technique allows properties of cancer cells and their surrounding tissue to be analyzed in detail at single-cell level (Photo courtesy of Universität Helsinki/Karolina Punovuori)

New Imaging Method Opens Door to Precision Diagnostics for Head and Neck Cancers

Head and neck cancers, while considered rare, represent a significant portion of cancer cases and have seen a notable increase over the past 30 years. These cancers encompass various malignant tumors that... Read more